The Latest Cardiac and Vascular News
– Single Doses of Investigational Zilebesiran Resulted in Sustained Serum Angiotensinogen and Blood Pressure Reductions Through Six Months, Supporting Quarterly and Potentially Biannual Dosing – – Blood Pressure Response to Low-Salt Intake under the Peak Pharmacodynamic Effect of Zilebesiran was Consistent with Augmented Pharmacology, with No Hypotensive Adverse Events Reported […]
— New, late-breaking data from the Leadless II IDE study confirm the Aveir™ leadless pacemaker achieved the pre-specified primary endpoints in treating patients with certain types of abnormal heart rhythms — Abbott’s Aveir system is the world’s only leadless pacemaker specifically designed to be retrieved when the device needs to […]
Acutus’ Catheter-Based Therapy Platform, AcQBlate Force, Will Integrate Multiple Ablation Modalities Guided by Novel Noncontact Mapping Technology to Treat Complex Atrial Arrhythmias CARLSBAD, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (Nasdaq: AFIB) (“Acutus”), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today […]
Sotera Wireless, Inc., a company specializing in healthcare technology, has announced that their remote patient monitoring system was successfully implemented in an emergency department. San Diego, United States, Nov. 11, 2021 (GLOBE NEWSWIRE) — The ViSi Mobile System from San Diego-based Sotera Wireless was recently implemented to help negate overcrowding […]
Continuous monitoring device with advanced features and analytics to deliver personalized insights directly to the smartphone REDWOOD CITY, Calif.–(BUSINESS WIRE)–Biotricity, Inc. (NASDAQ:BTCY), a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions, today announced the availability of Bioheart, a direct-to-consumer heart monitor that offers the same continuous heart monitoring technology […]
LILLESAND, Norway, Nov. 10, 2021 /PRNewswire/ — The innovative heart sensor ECG247, which has been developed and manufactured by Appsens AS in Norway, is shown to be better than the equipment most of the world’s hospitals and heart specialists use to find heart rhythm disorders, according to a new study published in the renowned […]
Non-Invasive Technology Requires No Vests, CT or MRI Imaging, or Invasive Mapping SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel computational ECG mapping system, vMap™. vMap is designed to map potential arrhythmia sources (hot spots) associated with stable or unstable […]
ScanWatch, which received FDA clearance for atrial fibrillation detection through ECG and measuring SpO2 levels from the wrist, becomes available in the United States ISSY-LES-MOULINEAUX, France, Nov. 9, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, begins U.S. sales of ScanWatch, its award-winning and most advanced health wearable to date. Available from […]
Latest installation follows a steady rise in patient cases conducted with the PURE EP™ System Westport, CT, Nov. 08, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]
– KARDIA-2 will Evaluate Efficacy and Safety of Zilebesiran when Used in Combination with Conventional Antihypertensive Medications – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced initiation of KARDIA-2, a global Phase 2 study to evaluate the efficacy and safety of zilebesiran (formerly known as […]
